Healthcare - Biotechnology - NASDAQ - US
$ 0.0003
0 %
$ 12.6 K
Market Cap
0.0
P/E
BALANCE SHEET
392 K
ASSETS
7.45 M
LIABILITIES
-6.56 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Scopus BioPharma Inc.
| Current Assets | 390 K |
| Cash & Short-Term Investments | 125 K |
| Receivables | 0 |
| Other Current Assets | 265 K |
| Non-Current Assets | 2.26 K |
| Long-Term Investments | 0 |
| PP&E | 2.26 K |
| Other Non-Current Assets | 0 |
| Current Liabilities | 7.45 M |
| Accounts Payable | 0 |
| Short-Term Debt | 0 |
| Other Current Liabilities | 7.45 M |
| Non-Current Liabilities | 0 |
| Long-Term Debt | 0 |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 0.1 | 7.9 | 1.8 | 36.7 K | 1.66 K | 0.2 |
| Short Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 562 | 27.9 K | 54.7 K |
| Inventory | 0 | 0 | 0 | 0.7 | 0 | 0 |
| Other Current Assets | 0.3 | 0.2 | 0.1 | 0.7 | 0.1 | 0 |
| Total Current Assets | 0.4 | 8.2 | 2.0 | 0.8 | 0.1 | 0.2 |
| PP&E | 2.26 K | 2.84 K | 2.33 K | 3.66 K | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 0.4 | 8.2 | 2.0 | 0.8 | 0.1 | 0.2 |
| LIABILITIES | ||||||
| Accounts Payable | 0 | 0 | 0 | 0 | 0 | 0 |
| Short Term Debt | 0 | 0 | 2.3 | 0 | 0 | 0 |
| Other Current Liabilities | 7.5 | 4.2 | 1.5 | 0.9 | 0.1 | 0.1 |
| Total Current Liabilities | 7.5 | 4.2 | 3.8 | 0.9 | 0.1 | 0.1 |
| Long Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 7.5 | 4.2 | 3.8 | 0.9 | 0.1 | 0.1 |
| EQUITY | ||||||
| Common Stock | 21.1 K | 21.1 K | 14.6 K | 12.5 K | 10.8 K | 10.4 K |
| Retained Earnings | (53.1) | (41.5) | (14.5) | (3.6) | (0.9) | (0.3) |
| Other Accumulative Comprehensive Income/Loss | 4.95 K | 86.7 K | 68.1 K | 33.5 K | 9.56 K | 0 |
| Total Equity | (7.1) | 4.0 | (1.8) | 82.9 K | 5.33 K | 0.1 |
| Total Liabilities and Equity | 0.4 | 8.2 | 2.0 | 0.8 | 0.1 | 0.2 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 21.1 | 17.3 | 13.4 | 15.0 | 15.0 |